Peer-influenced content. Sources you trust. No registration required. This is HCN.

Eyewire+Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health

The Center for Ophthalmic Artificial Intelligence and Human Health is one of the first in the US.

The Icahn School of Medicine at Mount Sinai has inaugurated a groundbreaking center dedicated to the advancement of artificial intelligence (AI) in ophthalmology. This initiative, the first of its kind in New York, aims to revolutionize patient care, education, and research in eye health, with a focus on early detection and intervention of various eye diseases and related systemic conditions.

Key Points:

  • In collaboration with the Windreich Department of Artificial Intelligence and Human Health, the Center will focus on AI-based diagnostic care in ophthalmology.
  • The initiative will explore AI’s role in diagnosing macular degeneration, diabetic retinopathy, glaucoma, hypertensive retinopathy, systemic conditions, and retinal tumors.
  • The Center will also research and implement AI models in Mount Sinai’s tele-retina program, ophthalmology tele-consult program, and eye stroke service.

Additional Points:

  • Early detection through AI can prevent vision loss and may also prevent heart attack and stroke.
  • The implementation of validated AI software could provide onsite interpretations of retinal scans and immediate patient referrals.
  • AI will transform Mount Sinai’s Eye Stroke Service to expedite diagnosis and treatment of acute eye strokes.
  • Researchers will develop unique ocular biomarkers using AI to inform the pathophysiology of eye diseases and streamline clinical trials.


  • The launch of this Center signifies a major step in integrating AI into ophthalmology, positioning Mount Sinai as a leader in innovative healthcare solutions.

“Artificial Intelligence is revolutionizing our society, especially in how we deliver health care to patients. Ophthalmology is at the forefront of this change since the image domain lends itself exceptionally well to modern deep learning-based AI. At Mount Sinai, we can realize the vision of an AI-driven ophthalmology that will drastically improve care for nearly every patient visiting our hospitals.”
Thomas J. Fuchs,, Dean of Artificial Intelligence and Human Health at Icahn Mount Sinai

Related Posts

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form